Abstract Background Seronegative ocular myasthenia gravis (OMG) is diagnosed by ocular symptoms with supporting SFEMG, typically of frontalis or extensor digitorum muscles. We aimed to determine the sensitivity and specificity of orbicularis oculi SFEMG to diagnose and exclude myasthenia gravis and predict response to therapy. Methods Orbicularis oculi SFEMG studies were conducted in 142 consecutive patients with symptoms and/or findings of OMG and negative AChR antibody during the period of 5 years. Retrospective chart review was conducted 2 years after the SFEMG to determine whether treatments were given and responses to treatment. Results Orbicularis oculi SFEMG was abnormal in 31 patients and normal in 111 patients. Twenty-nine patients...
OBJECTIVE To explore whether ocular vestibular evoked myogenic potentials (oVEMP) can be used to det...
The diagnosis of myasthenia gravis (MG) based on history and physical examination alone is difficult...
Around 60%--75% of myasthenia gravis (MG) patients initially present with nonspecific ocular symptom...
BACKGROUND: Seronegative ocular myasthenia gravis (OMG) is diagnosed by ocular symptoms with support...
Single-fibre electromyography (SF-EMG) is considered as the most sensitive test for the diagnosis of...
Objectives: To estimate the jitter parameters (single-fiber electromyography) in myasthenia gravis p...
We examined the findings from single-fiber electromyography in extensor digitorum communis (EDC) and...
BACKGROUND AND OBJECTIVE: In typical cases, the patient's history and clinical examination make it p...
The development of antibody tests and neurophysiological techniques have aided in confirming the dia...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
Objective To study clinical characteristics of ocular myasthenia gravis (OMG) to provide evidence fo...
OBJECTIVE: Our aim was to study the pathophysiological process leading to facial muscle atrophy in 1...
Myasthenia gravis is an autoimmune disease characterized by diplopia, ptosis, myasthenia, and ophtha...
Introduction: Diagnosis of myasthenia gravis (MG) can be challenging, especially in patients with is...
Introduction Diagnosing ocular myasthenia gravis (MG) can be challenging because serum antibodies ar...
OBJECTIVE To explore whether ocular vestibular evoked myogenic potentials (oVEMP) can be used to det...
The diagnosis of myasthenia gravis (MG) based on history and physical examination alone is difficult...
Around 60%--75% of myasthenia gravis (MG) patients initially present with nonspecific ocular symptom...
BACKGROUND: Seronegative ocular myasthenia gravis (OMG) is diagnosed by ocular symptoms with support...
Single-fibre electromyography (SF-EMG) is considered as the most sensitive test for the diagnosis of...
Objectives: To estimate the jitter parameters (single-fiber electromyography) in myasthenia gravis p...
We examined the findings from single-fiber electromyography in extensor digitorum communis (EDC) and...
BACKGROUND AND OBJECTIVE: In typical cases, the patient's history and clinical examination make it p...
The development of antibody tests and neurophysiological techniques have aided in confirming the dia...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
Objective To study clinical characteristics of ocular myasthenia gravis (OMG) to provide evidence fo...
OBJECTIVE: Our aim was to study the pathophysiological process leading to facial muscle atrophy in 1...
Myasthenia gravis is an autoimmune disease characterized by diplopia, ptosis, myasthenia, and ophtha...
Introduction: Diagnosis of myasthenia gravis (MG) can be challenging, especially in patients with is...
Introduction Diagnosing ocular myasthenia gravis (MG) can be challenging because serum antibodies ar...
OBJECTIVE To explore whether ocular vestibular evoked myogenic potentials (oVEMP) can be used to det...
The diagnosis of myasthenia gravis (MG) based on history and physical examination alone is difficult...
Around 60%--75% of myasthenia gravis (MG) patients initially present with nonspecific ocular symptom...